Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike

Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike·Investor's Business Daily

Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.

Advertisement